NASDAQ:CALA - Calithera Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.36 +0.14 (+2.68 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$5.22
Today's Range$5.12 - $5.37
52-Week Range$3.55 - $9.35
Volume171,842 shs
Average Volume145,117 shs
Market Capitalization$204.36 million
P/E Ratio-6.38
Dividend YieldN/A

Analyst Ratings

Calithera Biosciences (NASDAQ:CALA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Calithera Biosciences in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$14.00$14.00$14.00
Price Target Upside: N/A156.88% upside156.88% upside156.88% upside

Calithera Biosciences (NASDAQ:CALA) Consensus Price Target History

Price Target History for Calithera Biosciences (NASDAQ:CALA)

Calithera Biosciences (NASDAQ:CALA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/6/2018Leerink SwannReiterated RatingOutperformMediumView Rating Details
2/16/2018CitigroupUpgradeNeutral ➝ Buy$6.95 ➝ $14.00HighView Rating Details
10/5/2017William BlairInitiated CoverageOutperform ➝ OutperformN/AView Rating Details
6/12/2017HC WainwrightReiterated RatingBuy$14.00 ➝ $19.00LowView Rating Details
6/6/2017Wells Fargo & CoReiterated RatingOutperform$15.00 ➝ $20.00HighView Rating Details
3/28/2017JMP SecuritiesReiterated RatingOutperform$12.00 ➝ $12.00MediumView Rating Details
(Data available from 2/18/2017 forward)
This page was last updated on 2/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel